SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-127884
Filing Date
2022-12-16
Accepted
2022-12-16 16:41:32
Documents
4
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2232614-1_def14a.htm DEF 14A 263865
2 GRAPHIC lg_firstwavebiopharma-4c.jpg GRAPHIC 88336
3 GRAPHIC tm2232614d1-px_pg01firstbw.jpg GRAPHIC 816082
4 GRAPHIC tm2232614d1-px_pg02firstbw.jpg GRAPHIC 840525
  Complete submission text file 0001104659-22-127884.txt   2668765
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 221468484
SIC: 2834 Pharmaceutical Preparations